MX2015012199A - Composiciones de cisplatino liposomal para la terapia contra el cancer. - Google Patents
Composiciones de cisplatino liposomal para la terapia contra el cancer.Info
- Publication number
- MX2015012199A MX2015012199A MX2015012199A MX2015012199A MX2015012199A MX 2015012199 A MX2015012199 A MX 2015012199A MX 2015012199 A MX2015012199 A MX 2015012199A MX 2015012199 A MX2015012199 A MX 2015012199A MX 2015012199 A MX2015012199 A MX 2015012199A
- Authority
- MX
- Mexico
- Prior art keywords
- cisplatin
- cancer therapy
- mol
- liposomal cisplatin
- lipid
- Prior art date
Links
- DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 title abstract 5
- 229960004316 cisplatin Drugs 0.000 title abstract 5
- 239000000203 mixture Substances 0.000 title abstract 2
- 238000011275 oncology therapy Methods 0.000 title 1
- 206010028980 Neoplasm Diseases 0.000 abstract 2
- 201000011510 cancer Diseases 0.000 abstract 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract 2
- 239000002502 liposome Substances 0.000 abstract 2
- 235000012000 cholesterol Nutrition 0.000 abstract 1
- 150000002632 lipids Chemical class 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- -1 phosphatidylcholine lipid Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1277—Preparation processes; Proliposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
- A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361780272P | 2013-03-13 | 2013-03-13 | |
| PCT/US2014/026341 WO2014160337A1 (en) | 2013-03-13 | 2014-03-13 | Liposomal cisplatin compositions for cancer therapy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2015012199A true MX2015012199A (es) | 2015-11-30 |
Family
ID=50439522
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2015012199A MX2015012199A (es) | 2013-03-13 | 2014-03-13 | Composiciones de cisplatino liposomal para la terapia contra el cancer. |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US10039716B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2968142A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP6077710B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN105209017A (cg-RX-API-DMAC7.html) |
| BR (1) | BR112015022415A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2903254C (cg-RX-API-DMAC7.html) |
| MX (1) | MX2015012199A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2014160337A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5994049B2 (ja) * | 2012-10-01 | 2016-09-21 | 兵神装備株式会社 | 吐出システム |
| WO2016141167A1 (en) | 2015-03-03 | 2016-09-09 | Cureport, Inc. | Combination liposomal pharmaceutical formulations |
| US10736845B2 (en) * | 2015-03-03 | 2020-08-11 | Cureport Inc. | Dual loaded liposomal pharmaceutical formulations |
| US20170049701A1 (en) * | 2015-08-05 | 2017-02-23 | Steven M. Kushner | Clustoidal multilamellar soy lecithin phospholipid structures for transdermal, transmucosal, or oral delivery, improved intestinal absorption, and improved bioavailability of nutrients |
| EP3352733A1 (en) * | 2015-09-21 | 2018-08-01 | Mallinckrodt LLC | Improved stability of liposome formulations and uses thereof |
| SG11201805594PA (en) * | 2016-01-07 | 2018-07-30 | Univ Western Health Sciences | Formulations for treating bladder cancer |
| EP3416623B1 (en) | 2016-02-15 | 2021-08-11 | University of Georgia Research Foundation, Inc. | Ipa-3-loaded liposomes and methods of use thereof |
| US11266602B2 (en) * | 2016-05-16 | 2022-03-08 | Infectious Disease Research Institute | PEGylated liposomes and methods of use |
| CN110381922A (zh) * | 2017-01-18 | 2019-10-25 | 淡马锡生命科学研究院有限公司 | 超稳定脂质体增加对有丝分裂细胞的靶向作用 |
| US20190231690A1 (en) * | 2017-11-08 | 2019-08-01 | L.E.A.F. Holdings Group Llc | Platinum complexes and uses thereof |
| EP4117686B1 (en) | 2020-03-10 | 2024-12-04 | Chung Yuan Christian University | Liposome composition and preparation method thereof |
| TW202345843A (zh) * | 2022-04-06 | 2023-12-01 | 財團法人國家衛生研究院 | 脂質奈米顆粒及脂質體 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5843473A (en) * | 1989-10-20 | 1998-12-01 | Sequus Pharmaceuticals, Inc. | Method of treatment of infected tissues |
| US20020009488A1 (en) * | 1995-05-03 | 2002-01-24 | Polymasc Pharmaceuticals Plc | Tissue entrapment |
| EP0929293B1 (en) | 1996-08-23 | 2003-10-22 | Sequus Pharmaceuticals, Inc. | Liposomes containing a cisplatin compound |
| PT975329E (pt) | 1997-02-05 | 2005-03-31 | Upjohn Co | Complexos de lipidos e lipossomas de complexos de platina altamente insoluveis |
| MXPA02007320A (es) * | 2000-01-28 | 2004-07-30 | Alza Corp | Liposomas conteniendo un compuesto atrapado en solucion supersaturada. |
| EP1341497A4 (en) * | 2000-11-02 | 2005-10-19 | Smithkline Beecham Corp | RECEPTOR-LIPID ANTAGONIST CONJUGATES AND DELIVERY VEHICLES CONTAINING THE SAME |
| ES2290333T3 (es) * | 2001-11-13 | 2008-02-16 | Celator Pharmaceuticals, Inc. | Composiciones de vehiculos lipidicos y metodos para la retencion mejorada de farmacos. |
| EP1674081A1 (de) * | 2004-12-23 | 2006-06-28 | KTB Tumorforschungsgesellschaft mbH | Herstellung von lipidbasierten Nanopartikeln unter Einsatz einer dualen asymmetrischen Zentrifuge |
| JP2006248978A (ja) * | 2005-03-10 | 2006-09-21 | Mebiopharm Co Ltd | 新規なリポソーム製剤 |
| EP1716870A1 (en) * | 2005-04-29 | 2006-11-02 | Bracco Imaging S.p.A. | MRI contrast agents endowed with concentration independent responsiveness |
| US20100034874A1 (en) | 2006-12-08 | 2010-02-11 | Katayama Chemical Industries Co., Ltd. | Liposome encapsulating ammine-platinum complex at high concentration, and method for production of the liposome |
-
2014
- 2014-03-13 EP EP14715517.0A patent/EP2968142A1/en not_active Withdrawn
- 2014-03-13 BR BR112015022415A patent/BR112015022415A2/pt not_active IP Right Cessation
- 2014-03-13 JP JP2016502107A patent/JP6077710B2/ja not_active Expired - Fee Related
- 2014-03-13 MX MX2015012199A patent/MX2015012199A/es unknown
- 2014-03-13 CA CA2903254A patent/CA2903254C/en not_active Expired - Fee Related
- 2014-03-13 WO PCT/US2014/026341 patent/WO2014160337A1/en not_active Ceased
- 2014-03-13 US US14/208,297 patent/US10039716B2/en not_active Expired - Fee Related
- 2014-03-13 CN CN201480026589.0A patent/CN105209017A/zh active Pending
-
2018
- 2018-07-09 US US16/030,575 patent/US10383823B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US10039716B2 (en) | 2018-08-07 |
| CA2903254A1 (en) | 2014-10-02 |
| JP2016513651A (ja) | 2016-05-16 |
| JP6077710B2 (ja) | 2017-02-08 |
| CN105209017A (zh) | 2015-12-30 |
| US20180318219A1 (en) | 2018-11-08 |
| US10383823B2 (en) | 2019-08-20 |
| CA2903254C (en) | 2019-04-09 |
| EP2968142A1 (en) | 2016-01-20 |
| WO2014160337A1 (en) | 2014-10-02 |
| BR112015022415A2 (pt) | 2017-07-18 |
| US20140271821A1 (en) | 2014-09-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2015012199A (es) | Composiciones de cisplatino liposomal para la terapia contra el cancer. | |
| MX2015012200A (es) | Composiciones de oxaliplatino en liposomas para la terapia contra el cancer. | |
| MX2015012201A (es) | Formulaciones modificadas de liposomas de docetaxel. | |
| SG10201906075VA (en) | Methods of treating cancer | |
| MX2014004960A (es) | Composiciones liposomales combinadas para terapia contra el cancer. | |
| MX2015000811A (es) | Composiciones liposómicas de inhibidores de proteasoma basadas en epoxicetona. | |
| MX2021006723A (es) | Formulacion para anticuerpo anti-a4b7. | |
| IN2014DN05866A (cg-RX-API-DMAC7.html) | ||
| MX2012007981A (es) | Derivados de fumarato de acido graso y sus usos. | |
| WO2013188847A8 (en) | Compositions and methods for transmucosal absorption | |
| MY168791A (en) | Carbamate compounds and of making and using same | |
| IN2014MN00948A (cg-RX-API-DMAC7.html) | ||
| WO2013170012A3 (en) | Proliposomal testosterone formulations | |
| CA2882523C (en) | Lipid assemblies comprising anionic lysolipids and use thereof | |
| WO2008070463A3 (en) | Endoxifen methods and compositions | |
| GB2541835A (en) | Multivesicular liposome formulations of tranexamic acid | |
| PH12015501239A1 (en) | Oral care products comprising tetrabasic zinc chloride and trimethylglycine | |
| NZ708821A (en) | Lfa-1 inhibitor formulations | |
| WO2012117385A3 (en) | Liposome formulation comprising an anti-tumour active substance, method for its preparation and pharmaceutical compositions comprising it | |
| MX2014002780A (es) | Composiciones farmaceuticas que comprenden un inhibidor de aromatasa. | |
| PH12013500251A1 (en) | Oral care compositions | |
| WO2011143271A3 (en) | Therapeutic liposomes and methods for producing and using the same | |
| GB201114230D0 (en) | Addition copolymers and their use | |
| MX2012007682A (es) | Vacuna de aplicacion nasal contra el desarrollo de la enfermedad aterosclerotica y el higado graso. | |
| IN2015DN01223A (cg-RX-API-DMAC7.html) |